Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: Correlation with tumor response to fluorouracil

Journal of Clinical Oncology

Volumn 14, Issue 3, 1996, Pages 700-708

  Findlay, M ^a   Young, H ^a   Cunningham, D ^a   Iveson, A ^a   Cronin, B ^a   Hickish, T ^a   Pratt, B ^a   Husband, J ^a   Flower, M ^a   Ott, R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; FLUORODEOXYGLUCOSE; FLUOROURACIL; GLUCOSE;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DRUG EFFICACY; DRUG METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE QUALITY; LIVER METASTASIS; PHASE 3 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 9044226539     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.3.700     Document Type: Article

References (19)

1. Gupta NC, Falk P, Frank AR, et al: PET-FDG imaging for pre-operative staging of colorectal cancer. J Nucl Med 34:109, 1993 (abstr)
2. Nagata Y, Yamamoto K, Hiraoka M, et al: Monitoring liver tumor therapy with [(18)F]FDG positron emission tomography. J Comput Assist Tomogr 14:370-374, 1990
3. Strauss LG, Clorius JH, Schlag P, et al: Recurrence of colorectal tumors: PET evaluation. Radiology 170:329-332, 1989
4. Okazumi S, Isono K, Enomoto K, et al: Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET characterization of tumor and assessment of effect of treatment. J Nucl Med 33:333-339, 1992
5. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al: PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 32:1485-1490, 1991
6. Marsden PK, Ott RJ, Bateman JE, et al: The performance of a multiwire proportional chamber positron camera for clinical use. Phys Med Biol 34:1043-1062, 1989
7. Ott RJ: Wire chambers revisited. Eur J Nucl Med 20:348-358, 1993
8. Findlay M, Cunningham D, Hill ME, et al: Protracted venous infusion 5FU ± interferon-α 2b (Intron A) in patients with advanced colorectal cancer: Results of a phase III study and a parallel study measuring tumor fluorodeoxyglucose with positron emission tomography. Proc Am Soc Clin Oncol 13:193, 1994 (abstr 559)
9. Miller AB, Hoogstraaten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
10. Hamacher K, Coenen HH, Stocklin G: Efficient stereospecific synthesis of no carrier added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235-238, 1986
11. Robb RA, Hanson DP, Karwoski RA, et al: Analyse: A comprehensive operator interactive software package for multidimensional medical image display and analysis. Comput Med Imaging Graph 13:433-454, 1989
12. Grem JL, McAtee N, Murphy RF: A pilot study of interferon-alfa 2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma. J Clin Oncol 9:1811-1820, 1991
13. Higashi K, Anaira CC, Wahl RL: Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 34:414-419, 1993
14. Minn H, Leskinen Kallio S, Lindholm P, et al: [(18)F]fluorodeoxyglucose uptake in tumors: Kinetic vs. steady-state methods with reference to plasma insulin. J Comput Assist Tomogr 17:115-123, 1993
15. Sokaloff L, Reivich M, Kennedy C, et al: The [14-C]deoxyglucose method for measurement of local cerebral glucose utilisation: Theory, procedure, and normal values in the conscious and anesthetised albino rat. J Neurochem 28:897-916, 1977
16. Hamberg L, Hunter GJ, Alpert N, et al: The dose uptake ratio as an index of glucose metabolism: Useful parameter or oversimplification? J Nucl Med 35:1308-1312, 1994
17. Zasadny K, Whal RL: Standardised uptake values of normal tissues at FDG-PET: Variations with body weight. J Nucl Med 34:186, 1993 (abstr)
18. DeGrado TR, Turkington TG, Stearns CW, et al: Performance characteristics of a whole-body scanner. J Nucl Med 35:1398-1406, 1994
19. Kubota R, Yamada S, Kubota K, et al: Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972-1980, 1992